Annual EBITDA
Summary
- Status
- ARXS annual EBITDA is unknown
EBITDA Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | - | – | – | – | – | |
| Quarterly EBITDA | $170.25M | +54.2% | +54.2% | +54.2% | +54.2% | |
| TTM EBITDA | $170.25M | +54.2% | +54.2% | +54.2% | +54.2% | |
| Price | $40.45 | – | – | – | – | |
| PE Ratio | 311.39 | – | – | – | – | |
| Annual Revenue | - | – | – | – | – | |
| Annual EPS | $0.00 | +100.0% | +100.0% | +100.0% | +100.0% | |
| $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | ||
| Annual Net Income | - | – | – | – | – |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $204.36M | N/A | |
| 5Y | $204.36M | N/A | |
| All | $204.36M | N/A |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $120.49M | N/A | |
| 5Y | $120.49M | N/A | |
| All | $120.49M | N/A |
EBITDA History
| Year | Value | Change |
|---|---|---|
| $204.36M | +69.6% |
| Year | Value | Change |
|---|---|---|
| $120.49M | - |
FAQ
What is the current annual EBITDA of ARXS?
ARXS annual EBITDA is unknown
What is 1-year change in ARXS annual EBITDA?
ARXS annual EBITDA 1-year change is unknown
What is 3-year change in ARXS annual EBITDA?
ARXS annual EBITDA 3-year change is unknown
How far is ARXS annual EBITDA from its all-time high?
ARXS annual EBITDA vs all-time high is unknown
When is ARXS next annual earnings release?
As of today, the next annual earnings release for ARXS has not been scheduled
EBITDA Formula
Quarterly EBITDA
Summary
- Current Value
- As of today, ARXS quarterly EBITDA is $170.25M, up +54.17% on
- Historical Performance
- ARXS quarterly EBITDA is up +54.17% year-over-year, up +54.17% over the past 3 years
- All-Time High Comparison
- ARXS quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ARXS quarterly EBITDA is +54.17% above its 3-year low of $110.43M reached on
- Sector Comparison
- ARXS quarterly EBITDA is higher than 74.03% of companies in Industrials sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $170.25M | 0.0% | +54.2% | +54.2% | +54.2% | |
| Annual EBITDA | - | – | – | – | – | |
| TTM EBITDA | $170.25M | 0.0% | +54.2% | +54.2% | +54.2% | |
| Price | $40.45 | – | – | – | – | |
| PE Ratio | 311.39 | – | – | – | – | |
| Quarterly Revenue | $458.86M | 0.0% | +20.7% | +20.7% | +20.7% | |
| Quarterly EPS | $0.13 | 0.0% | +1314.0% | +1314.0% | +1314.0% | |
| $118.72M | 0.0% | +93.3% | +93.3% | +93.3% | ||
| Quarterly Net Income | $53.31M | 0.0% | +1332.9% | +1332.9% | +1332.9% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $170.25M | at high | |
| 3Y | $170.25M | at high | |
| 5Y | $170.25M | at high | |
| All | $170.25M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $110.43M | N/A | +54.2% |
| 3Y | $110.43M | +54.2% | |
| 5Y | $110.43M | +54.2% | |
| All | $110.43M | +54.2% |
Quarterly EBITDA History
| Month | Value | Change |
|---|---|---|
| $170.25M | +54.2% |
| Month | Value | Change |
|---|---|---|
| $110.43M | - |
FAQ
What is the current quarterly EBITDA of ARXS?
As of today, ARXS quarterly EBITDA is $170.25M
What is ARXS quarterly EBITDA most recent change?
ARXS quarterly EBITDA was up +54.17% on March 1, 2026
What is 1-year change in ARXS quarterly EBITDA?
ARXS quarterly EBITDA is up +54.17% year-over-year
How far is ARXS quarterly EBITDA from its all-time high?
ARXS quarterly EBITDA is currently at its all-time high
How does ARXS quarterly EBITDA rank versus sector peers?
ARXS quarterly EBITDA is higher than 74.03% of companies in Industrials sector
When is ARXS next earnings release?
The next earnings release for ARXS is on
EBITDA Formula
TTM EBITDA
Summary
- Current Value
- As of today, ARXS TTM EBITDA is $170.25M, up +54.17% on
- Historical Performance
- ARXS TTM EBITDA is up +54.17% year-over-year, up +54.17% over the past 3 years
- All-Time High Comparison
- ARXS TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ARXS TTM EBITDA is +54.17% above its 3-year low of $110.43M reached on
- Sector Comparison
- ARXS TTM EBITDA is higher than 53.06% of companies in Industrials sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $170.25M | 0.0% | +54.2% | +54.2% | +54.2% | |
| Annual EBITDA | - | – | – | – | – | |
| Quarterly EBITDA | $170.25M | 0.0% | +54.2% | +54.2% | +54.2% | |
| Price | $40.45 | – | – | – | – | |
| PE Ratio | 311.39 | – | – | – | – | |
| TTM Revenue | $458.86M | 0.0% | +20.7% | +20.7% | +20.7% | |
| TTM EPS | $0.13 | 0.0% | +1314.0% | +1314.0% | +1314.0% | |
| $118.72M | 0.0% | +93.3% | +93.3% | +93.3% | ||
| TTM Net Income | $53.31M | 0.0% | +1332.9% | +1332.9% | +1332.9% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $170.25M | at high | |
| 3Y | $170.25M | at high | |
| 5Y | $170.25M | at high | |
| All | $170.25M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $110.43M | N/A | +54.2% |
| 3Y | $110.43M | +54.2% | |
| 5Y | $110.43M | +54.2% | |
| All | $110.43M | +54.2% |
TTM EBITDA History
| Month | Value | Change |
|---|---|---|
| $170.25M | +54.2% |
| Month | Value | Change |
|---|---|---|
| $110.43M | - |
FAQ
What is the current TTM EBITDA of ARXS?
As of today, ARXS TTM EBITDA is $170.25M
What is ARXS TTM EBITDA most recent change?
ARXS TTM EBITDA was up +54.17% on March 1, 2026
What is 1-year change in ARXS TTM EBITDA?
ARXS TTM EBITDA is up +54.17% year-over-year
How far is ARXS TTM EBITDA from its all-time high?
ARXS TTM EBITDA is currently at its all-time high
How does ARXS TTM EBITDA rank versus sector peers?
ARXS TTM EBITDA is higher than 53.06% of companies in Industrials sector
When is ARXS next earnings release?
The next earnings release for ARXS is on
EBITDA Formula
Data Sources & References
- ARXS Official Website www.arxis.com
- ARXS Profile on Yahoo Finance finance.yahoo.com/quote/ARXS
- ARXS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/arxs